These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 36301507)

  • 1. Understanding the Crosstalk Between Epigenetics and Immunometabolism to Combat Cancer.
    Seth A; Kar S
    Subcell Biochem; 2022; 100():581-616. PubMed ID: 36301507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
    Pan X; Zheng L
    Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Control of Epigenetics and Its Role in CD8
    Yerinde C; Siegmund B; Glauben R; Weidinger C
    Front Immunol; 2019; 10():2718. PubMed ID: 31849941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single cell cancer epigenetics.
    Casado-Pelaez M; Bueno-Costa A; Esteller M
    Trends Cancer; 2022 Oct; 8(10):820-838. PubMed ID: 35821003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
    Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
    Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer.
    Das D; Karthik N; Taneja R
    Subcell Biochem; 2022; 100():523-555. PubMed ID: 36301505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and epigenetics at the heart of T cell function.
    Soriano-Baguet L; Brenner D
    Trends Immunol; 2023 Mar; 44(3):231-244. PubMed ID: 36774330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic recoding of epigenetics in cancer.
    Wang YP; Lei QY
    Cancer Commun (Lond); 2018 May; 38(1):25. PubMed ID: 29784032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of immune synapse genes modulates tumor immunogenicity.
    Berglund A; Mills M; Putney RM; Hamaidi I; Mulé J; Kim S
    J Clin Invest; 2020 Feb; 130(2):974-980. PubMed ID: 31714899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
    Yang Y; Wang Y
    Front Immunol; 2021; 12():640369. PubMed ID: 33868269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging epigenetics to enhance the efficacy of immunotherapy.
    Licht JD; Bennett RL
    Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
    Lodewijk I; Nunes SP; Henrique R; Jerónimo C; Dueñas M; Paramio JM
    Clin Epigenetics; 2021 Mar; 13(1):63. PubMed ID: 33761971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
    Tien FM; Lu HH; Lin SY; Tsai HC
    J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming and epigenetic modifications on the path to cancer.
    Sun L; Zhang H; Gao P
    Protein Cell; 2022 Dec; 13(12):877-919. PubMed ID: 34050894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connections between Metabolism and Epigenetic Modification in MDSCs.
    Dai H; Xu H; Wang S; Ma J
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.